Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma
J. Clin. Oncol 2021 Aug 31;[EPub Ahead of Print], RHI Andtbacka, B Curti, GA Daniels, S Hallmeyer, ED Whitman, J Lutzky, LE Spitler, K Zhou, PK Bommareddy, M Grose, M Wang, C Wu, HL KaufmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.